ATE107171T1 - Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen. - Google Patents

Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen.

Info

Publication number
ATE107171T1
ATE107171T1 AT88907876T AT88907876T ATE107171T1 AT E107171 T1 ATE107171 T1 AT E107171T1 AT 88907876 T AT88907876 T AT 88907876T AT 88907876 T AT88907876 T AT 88907876T AT E107171 T1 ATE107171 T1 AT E107171T1
Authority
AT
Austria
Prior art keywords
polysaccharide
veterinary
negative
pathogenic
bacillies
Prior art date
Application number
AT88907876T
Other languages
English (en)
Inventor
Neylan A Vedros
Te-Ning Ernie Liu
Original Assignee
Biotech Connections Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Connections Int Inc filed Critical Biotech Connections Int Inc
Application granted granted Critical
Publication of ATE107171T1 publication Critical patent/ATE107171T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT88907876T 1987-08-05 1988-08-03 Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen. ATE107171T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/081,942 US4877613A (en) 1987-08-05 1987-08-05 Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli

Publications (1)

Publication Number Publication Date
ATE107171T1 true ATE107171T1 (de) 1994-07-15

Family

ID=22167392

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88907876T ATE107171T1 (de) 1987-08-05 1988-08-03 Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen.

Country Status (8)

Country Link
US (1) US4877613A (de)
EP (1) EP0374178B1 (de)
JP (1) JPH03501123A (de)
AT (1) ATE107171T1 (de)
AU (1) AU615217B2 (de)
CA (1) CA1327749C (de)
DE (1) DE3850257T2 (de)
WO (1) WO1989000860A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225194A (en) * 1989-11-13 1993-07-06 Ldc Research Corporation Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
US6100066A (en) * 1992-04-09 2000-08-08 University Of Saskatchewan Nucleic acid molecules encoding Haemophilus somnus proteins
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US5951987A (en) * 1995-08-22 1999-09-14 Her Majesty The Queen As Represented By The Minister Of National Defence Of Her Majesty'canadian Government Polysaccharide vaccine to enhance immunity against brucellosis
PT897427E (pt) * 1996-02-14 2005-01-31 Merck & Co Inc Processo de precipitacao de polissacarideos
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
US6280741B1 (en) 1999-08-19 2001-08-28 Ed C. Jessup Equine treatment and method of administering such treatment
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN113088101B (zh) 2014-05-21 2023-07-04 罗利克技术有限公司 可聚合的二色性染料

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA709832A (en) * 1965-05-18 Nakazawa Masao Preparation of purified lipid a from crude lipid a derived from lipopolysaccharides of gram-negative bacteria
GB886597A (en) * 1958-11-14 1962-01-10 Pfizer & Co C Process for producing lipopolysaccharides and compositions containing the same
GB1426042A (en) * 1971-11-26 1976-02-25 Anvar water-soluble immunological adjuvants
SU594173A1 (ru) * 1975-07-25 1978-02-25 Всесоюзный Научно-Исследовательский Институт По Болезням Птиц Способ получени антигена дл диагностики пуллороза-тифа птиц
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4413057A (en) * 1980-04-14 1983-11-01 Merck & Co., Inc. Group B streptococcal capsular polysaccharides
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
SU1084293A1 (ru) * 1982-08-25 1984-04-07 Горьковский Научно-Исследовательский Институт Эпидемиологии И Микробиологии Способ получени антигена дл серологической диагностики сальмонеллеза
EP0109688A3 (de) * 1982-11-23 1986-12-03 The Wellcome Foundation Limited Komplexe, Verfahren zu deren Herstellung und diese Komplexe enthaltende Zusammensetzungen
US4686102A (en) * 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine

Also Published As

Publication number Publication date
JPH03501123A (ja) 1991-03-14
AU2307888A (en) 1989-03-01
EP0374178A1 (de) 1990-06-27
EP0374178A4 (en) 1990-09-26
CA1327749C (en) 1994-03-15
DE3850257D1 (de) 1994-07-21
US4877613A (en) 1989-10-31
WO1989000860A1 (en) 1989-02-09
EP0374178B1 (de) 1994-06-15
AU615217B2 (en) 1991-09-26
DE3850257T2 (de) 1994-09-22

Similar Documents

Publication Publication Date Title
ATE5001T1 (de) Verfahren zur herstellung eines ausgewaehlten proteins.
ATE107171T1 (de) Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen.
PT626998E (pt) "producao de plantas resistentes aos virus, mediante introducao de uma molecula de arn viral nao traduzivel e de sentido codificador"
ES531986A0 (es) Un metodo de producir una forma geneticamente estable de vidrio cholerae
DE69217491D1 (de) Verfahren zur enzymatischen herstellung von alpha-sialylierten oligosaccharid-glykosiden
ATE7201T1 (de) Verfahren zur herstellung eines bakteriellen praeparates zur verhuetung von darmbeschwerden beim gefluegel.
CH659480A5 (de) Verfahren zur effektivierung der erzeugung von proteinen und rekombinantes dns-molekuel.
NL300307I1 (nl) Werkwijzen voor de replicatie van influenzavirussen in celkweek en de influenzavirussen die verkrijgbaar zijn met behulp van de werkwijze
FI885464A7 (fi) Asyylioksiasyylihydrolaasi ja sen käyttö
DE3862071D1 (de) Kathode fuer elektrolyse und verfahren zur herstellung derselben.
DE68920708D1 (de) Hoch dispergierbares Magnesiumoxid und Verfahren zur Herstellung davon.
DE3669531D1 (de) Verfahren zur herstellung eines modifizierten polysaccharides.
FR2444464B1 (de)
ATE123069T1 (de) Verfahren zur herstellung von humanem faktor viii und dessen analogen.
DE3686300D1 (de) Calcium- und magnesiumkomplexe von phytohaemagglutinin-polyheteroglykanen, ihre herstellung und pharmazeutische zubereitungen.
ATE123947T1 (de) Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten.
DE59101580D1 (de) Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.
CA2231332A1 (en) Bacterial delivery system
DE3769096D1 (de) Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion.
ATE156190T1 (de) Familie von auf xanthan basierenden polysaccharidpolymeren, welche nichtacetylierten und/oder nichtpyruvylierten gum beeinhalten
ES2397516T3 (es) Procedimiento de aislamiento de endotoxinas
DE69012589D1 (de) Verfahren zur herstellung von kontinuierlich stirngefrästen kegelzahnrädern mit abgeschrägten zahnstirnkanten.
ATE206165T1 (de) Verfahren zur herstellung von l-leucin
US4503036A (en) Process for producing a biochemical vaccine against Salmonella infection
ATE215784T1 (de) Verfahren zur herstellung eines kappa-casein- glykomakropeptides oder eines abkoemmlings davon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties